Flash
›
Syntara Limited (SNT.AX) Deep Dive Video
Syntara Limited (SNT.AX) Deep Dive Video
Summary
A restructured ASX micro-cap biotech betting on first-in-class pan-LOX inhibition—five 2026 readouts could unlock a major re-rating, but the path is highly binary and partner-dependent.
View SNT.AX stock page
·
Read the SNT.AX research report
Loading the video player…